ORGO
Organogenesis Holdings Inc. · Healthcare
Insiders bought $40K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Mar 11, 2026
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Apr 25, 2026
Leibowitz Arthur S
Organogenesis Holdings Inc. (ORGO) has 35 SEC Form 4 filings (81 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Apr 25, 2026.
Inside the rolling window, 3 insiders at Organogenesis Holdings Inc. reported 4 open-market purchases totaling $1.1M and 6 open-market sales totaling $2.7M. The most active filer is Director NUSSDORF GLENN H with 8 filings. Insiders have net sold $1.6M over the trailing 6 months. The most recent open-market filing is a purchase of 5,000 shares by Director Leibowitz Arthur S, dated Mar 9, 2026, worth $13K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Gary S. Gillheeney
- Employees:869
- HQ:Canton, MA, US
- IPO:2017-01-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
Leibowitz Arthur SFirst filing | Director | Purchase | 5,000 | $13K | Mar 11 | +0.4% | SEC ↗ |
Driscoll Michael JosephFirst filing | Director | Purchase | 10,000 | $27K | Mar 11 | +0.4% | SEC ↗ |
| Director | Sale | 200,000 | $1.0M | Dec 18 | -53.6% | SEC ↗ | |
| Director, 10% Owner | Sale | 100,000 | $534K | Nov 26 | -50.6% | SEC ↗ | |
| Director, 10% Owner | Sale | 12,043 | $64K | Nov 26 | -50.6% | SEC ↗ | |
| Director, 10% Owner | Sale | 187,957 | $994K | Nov 26 | -50.6% | SEC ↗ | |
NUSSDORF GLENN HFirst filing | Director, 10% Owner | Purchase | 251,001 | $775K | Nov 3 | -33.0% | SEC ↗ |
NUSSDORF GLENN HFirst filing | Director, 10% Owner | Purchase | 107,494 | $321K | Nov 3 | -33.0% | SEC ↗ |
NUSSDORF GLENN HFirst filing | Director, 10% Owner | Sale | 4,156 | $15K | Nov 3 | -33.0% | SEC ↗ |
NUSSDORF GLENN HFirst filing | Director, 10% Owner | Sale | 18,620 | $66K | Nov 3 | -33.0% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ORGO have?
Organogenesis Holdings Inc. (ORGO) has 35 SEC Form 4 filings (81 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Apr 25, 2026.
When was the most recent SEC Form 4 filing for ORGO?
The most recent Form 4 filing for ORGO on Tracefour is dated Apr 25, 2026.
Who is the most active insider at ORGO?
The most active SEC Form 4 filer at ORGO in the rolling window is Director NUSSDORF GLENN H, with 8 filings.
What is the net insider flow at ORGO over the last 6 months?
Over the trailing 180 days, insiders at ORGO have net sold $1.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ORGO in the current window?
Inside the rolling window, insiders at ORGO bought $1.1M and sold $2.7M based on SEC Form 4 filings.
Can I get alerts for ORGO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Organogenesis Holdings Inc. (ORGO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Organogenesis Holdings Inc. is in the Healthcare sector.